Patents by Inventor Mauro Magnani

Mauro Magnani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230406912
    Abstract: The present invention relates to humanised antibody molecules having specificity for ?-1,3 glucans and compositions comprising the same. The present invention also relates to the therapeutic uses of the antibody molecules, wherein said use is in the treatment or prophylaxis of fungal infections. It is further claimed a synergistic combination of a) at least one humanised antibody which has specificity for ?-1,3 glucans and b) one or more antifungal agents for use in the treatment or prophylaxis of infections of human cells.
    Type: Application
    Filed: November 2, 2021
    Publication date: December 21, 2023
    Inventors: Tomas DI MAMBRO, Tania VANZOLINI, Mauro MAGNANI
  • Patent number: 10619208
    Abstract: The present invention relates to a novel procedure for evaluating the response of patients affected by Ataxia Talangiectasia (A-T) to glucocorticoids treatment. In particular, the procedure provides a step of qualitative and/or quantitative identification in the blood of said patients of the expression of a mRNA variant of the ATM (Ataxia-Talangiectasia-Mutated) gene produced by non-canonical splicing induced by glucocorticoid (GC). In fact, it was demonstrated that mRNA variant expression is present in the blood of patients who responded positively to treatment with GC.
    Type: Grant
    Filed: January 19, 2016
    Date of Patent: April 14, 2020
    Assignee: EryDel S.p.A.
    Inventors: Mauro Magnani, Sara Biagiotti, Michele Menotta
  • Publication number: 20180016637
    Abstract: The present invention relates to a novel procedure for evaluating the response of patients affected by Ataxia Talangiectasia (A-T) to glucocorticoids treatment. In particular, the procedure provides a step of qualitative and/or quantitative identification in the blood of said patients of the expression of a mRNA variant of the ATM (Ataxia-Talangiectasia-Mutated) gene produced by non-canonical splicing induced by glucocorticoid (GC). In fact, it was demonstrated that mRNA variant expression is present in the blood of patients who responded positively to treatment with GC.
    Type: Application
    Filed: January 19, 2016
    Publication date: January 18, 2018
    Inventors: Mauro MAGNANI, Sara BIAGIOTTI, Michele MENOTTA
  • Patent number: 9629933
    Abstract: Erythrocytes exposed to dialysis with an hypotonic buffer stably take up superparamagnetic iron oxide nanoparticles and may be used MRI contrast agents. Such erythrocytes may also be used as drug delivery vehicles.
    Type: Grant
    Filed: July 3, 2007
    Date of Patent: April 25, 2017
    Assignee: Erydel S.P.A.
    Inventors: Mauro Magnani, Antonella Antonelli
  • Patent number: 9428557
    Abstract: Tat protein produced in bulk culture is inactive when induced at conventional optical densities but can be obtained in biologically active form when induced during the logarithmic growth phase.
    Type: Grant
    Filed: February 6, 2009
    Date of Patent: August 30, 2016
    Assignees: ISTITUTO SUPERIORE DI SANITA, UNIVERSITA DEGLI STUDI DI URBINO
    Inventors: Barbara Ensoli, Mauro Magnani
  • Publication number: 20140202857
    Abstract: The present invention concerns a device and a method of single-molecule analysis by detection of a target molecule on functionalized nanopores in such a way that it interacts with the target molecule and has an effective diameter smaller than the dimension of the target molecule.
    Type: Application
    Filed: May 23, 2012
    Publication date: July 24, 2014
    Applicant: Universita Degli Studi Di Genova
    Inventors: Ugo Valbusa, Luca Repetto, Giuseppe Firpo, Valentina Mussi, Paola Fanzio, Chiara Manneschi, Gian Paolo Tonini, Paola Scaruffi, Sara Stigliani, Michele Menotta, Mauro Magnani
  • Patent number: 8734787
    Abstract: Red blood cells can be used as effective drug delivery systems when they contain proteins that do not readily diffuse out and which form affinity complexes with the desired drug.
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: May 27, 2014
    Assignee: Erydel S.p.A.
    Inventors: Mauro Magnani, Luigia Rossi, Sara Biagiotti, Marzia Bianchi
  • Publication number: 20120165248
    Abstract: Glutathione derivatives (GSH) of formula I are provided, wherein R is a thiol protection group. The derivatives are useful for the treatment of infections from Paramyxovirus, Orthomyxovirus, Herpes Simplex Virus and Acquired Immunodeficiency Syndrome Virus.
    Type: Application
    Filed: October 12, 2011
    Publication date: June 28, 2012
    Applicant: fiRST S.r.l.
    Inventors: Umberto Benatti, Giorgio Brandi, Enrico Garaci, Mauro Magnani, Enrico Millo, Anna Taresa Palamara, Luigia Rossi
  • Publication number: 20120141540
    Abstract: Red blood cells can be used as effective drug delivery systems when they contain proteins that do not readily diffuse out and which form affinity complexes with the desired drug.
    Type: Application
    Filed: June 7, 2010
    Publication date: June 7, 2012
    Inventors: Mauro Magnani, Luigia Rossi, Sara Biagiotti, Marzia Bianchi
  • Publication number: 20110319593
    Abstract: Tat protein produced in bulk culture is inactive when induced at conventional optical densities but can be obtained in biologically active form when induced during the logarithmic growth phase.
    Type: Application
    Filed: February 6, 2009
    Publication date: December 29, 2011
    Inventors: Barbara Ensoli, Mauro Magnani
  • Publication number: 20100061937
    Abstract: Erythrocytes exposed to dialysis with an hypotonic buffer stably take up superparamagnetic iron oxide nanoparticles and may be used MRI contrast agents. Such erythrocytes may also be used as drug delivery vehicles.
    Type: Application
    Filed: July 3, 2007
    Publication date: March 11, 2010
    Inventors: Mauro Magnani, Antonella Antonelli
  • Patent number: 7645788
    Abstract: Use of the tetramerous derivative of indole-3-carbinol having formula I for preparing a medicinal having anti-carcinogenic activity, and method of synthesis of the tetramerous derivative having formula I, in which indole-3-carbinol is reacted with an oxidizing agent so as to cause a polymeric oxidation of indole-3-carbinol.
    Type: Grant
    Filed: June 5, 2002
    Date of Patent: January 12, 2010
    Assignee: Universita' Degli Studi Di Urbino
    Inventors: Mauro Magnani, Chiara Fiorucci, Paolino Filippone, Giorgio Brandi, Mirko Paiardini
  • Publication number: 20070270349
    Abstract: Glutathione derivatives (GSH) of formula (I) are provided, wherein R is a thiol protection group. The derivatives are useful for the treatment of infections from Paramyxovirus, Orthomyxovirus, Herpes Simplex Virus and Acquired Immunodeficiency Syndrome Virus.
    Type: Application
    Filed: December 29, 2004
    Publication date: November 22, 2007
    Inventors: Umberto Benatti, Giorgio Brandi, Enrico Garaci, Mauro Magnani, Enrico Millo, Anna Palamara, Luigia Rossi
  • Publication number: 20040214876
    Abstract: Use of the tetramerous derivative of indole-3-carbinol having formula I 1
    Type: Application
    Filed: June 9, 2004
    Publication date: October 28, 2004
    Inventors: Mauro Magnani, Chiara Fiorucci, Paolino Filippone, Giorgio Brandi, Mirko Palardini
  • Patent number: 6377398
    Abstract: A panoramic telescope of the type having a body 3 to be mounted on a vehicle, a head-piece 9 attached to the body and rotating with respect thereto. A window 11 is provided for observing the external scenery. Inside the head-piece is a mirror 13 for deflecting the incoming beam from the window towards an optical detector.
    Type: Grant
    Filed: April 27, 2000
    Date of Patent: April 23, 2002
    Assignee: Finmeccanica S.p.A. Ramo di Azienda DiFesa
    Inventors: Silvano Pieri, Mauro Magnani, Mario Cecchi
  • Patent number: 6339497
    Abstract: A panoramic periscope includes a central body (3, 3A) and a rotating head-piece (9) supported on the central body. Inside the central body, an optical path (21, 23, 101, 105, 109, 111, 113) for an optical beam (F,) coming from the head-piece (9) is provided. A viewing module (17) receives the optical beam, for observing the external scenery. A laser telemeter (19) is provided and, along the optical path, a separator element (10S) with an inner dichroic surface (105A) is passed through by the optical beam coming from the head-piece (9). The inner dichroic surface (105A) separates a laser beam coming from the head-piece (9) and deviating it towards a separate optical path (107) which conveys the laser beam towards the laser telemeter (19). The separator element (105) has an entry surface (105I) and an exit surface (105U) which are parallel with one another and passed through by the optical beam (FV), the surfaces being perpendicular to the optical beam (FV).
    Type: Grant
    Filed: July 17, 2000
    Date of Patent: January 15, 2002
    Assignee: Finmeccanica S.p.A. Ramo di Azienda Alenia Difesa
    Inventors: Silvano Pieri, Mauro Magnani, Mario Cecchi
  • Patent number: 6166377
    Abstract: An infrared image sensor, in particular one of the interlaced parallel scanning type, is described. The infrared image sensor has an optical focusing system for focusing an image on a matrix of sensitive elements (55) for the detection of the image. A collimator unit (5) forms a focal plane. The collimator unit is disposed at the entry of the sensor. At least one thermal reference (33), whose image is projected on the matrix (55), is disposed on the optical path of the image inside the sensor.
    Type: Grant
    Filed: September 18, 1998
    Date of Patent: December 26, 2000
    Assignee: Finmeccanica S.p.A. Ramo di Azienda Alenia Difesa
    Inventors: Silvano Pieri, Mauro Magnani, Monica Olivieri
  • Patent number: 6139836
    Abstract: A method and apparatus for the encapsulation of biologically active agents in red blood cells (RBCS) is disclosed. The method is characterized in that lysed and partially lysed RBCs are concentrated prior to the introduction of the biologically active agent. The resultant carrier RBCs are stable for an extended period of time under physiological conditions and can be used for the systemic or targeted delivery of therapeutically effective amounts of one or more biologically active agents to a patient.
    Type: Grant
    Filed: May 1, 1998
    Date of Patent: October 31, 2000
    Assignee: Dideco, S.p.A.
    Inventors: Mauro Magnani, Ivo Panzani, Leonardo Bigi, Andrea Zanella
  • Patent number: 6124968
    Abstract: A panoramic telescope of the type having a body 3 to be mounted on a vehicle, a head-piece 9 attached to the body and rotating with respect thereto. A window 11 is provided for observing the external scenery. Inside the head-piece is a mirror 13 for deflecting the incoming beam from the window towards an optical detector.
    Type: Grant
    Filed: October 30, 1998
    Date of Patent: September 26, 2000
    Assignee: Finmeccanica S.p.A.
    Inventors: Silvano Pieri, Mauro Magnani, Mario Cecchi
  • Patent number: 5753221
    Abstract: The invention relates to compositions of erythrocytes that have been modified following hypotonic lysis and resealing by addition of 2',3'-dideoxycytidine-5'-triphosphate (ddCTP) or 3'-azido-3'-deoxythymidine-5'-triphosphate (AZT-TP). These compositions may also contain ATP. Also disclosed are methods of preparing these compositions.
    Type: Grant
    Filed: November 3, 1993
    Date of Patent: May 19, 1998
    Assignee: Communaute Economique Europeene
    Inventors: Mauro Magnani, Luigia Rossi